Nurea

Precision imaging for heart and brain diagnosis.

Image
Florian Bernard
Florian Bernard

CEO

Image
Romain Leguay
Romain Leguay

CTO

Nurea develops advanced medical imaging software designed to prevent and diagnose cardiovascular and neurovascular diseases. These conditions are the leading cause of death globally, costing healthcare systems in the U.S. and Europe over $560 billion annually. 

Nurea's technology enables early detection by creating 3D reconstructions of patients' arterial systems from standard 2D medical images, allowing clinicians to monitor structural changes over time. This innovative approach can identify early signs of aneurysms and other conditions before they become life-threatening, offering a highly accurate, operator-independent solution that integrates seamlessly into hospital systems.

Nurea's technology stands out for its ability to generate precise digital twins of patients' arterial networks, improving both pre-operative planning and post-operative follow-up. 

Linkedin

Crunchbase

Newfund investors: Anne-Sophie Saint-Martin et Agathe Descamps